Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
A. Gemelli University Hospital, Rome, Italy.
Acta Neurochir (Wien). 2018 Aug;160(8):1531-1538. doi: 10.1007/s00701-018-3571-3. Epub 2018 Jun 4.
There is currently no consensus as to whether meningiomas located inside the venous sinuses should be aggressively or conservatively treated. The goals of this study were to identify how sinus-invading meningiomas grow, report and compare growth rates of tumor components inside and outside the different venous sinuses, identify risk factors associated with increased tumor growth, and determine the effects of the extent of tumor resection on recurrence for meningiomas that invade the dural venous sinuses.
Adult patients who underwent primary, non-biopsy resection of a WHO grade 1 meningioma invading the dural venous sinuses at a tertiary care institution between 2007 and 2015 were retrospectively reviewed. Rates of tumor growth were fit to several growth models to evaluate the most accurate model. Cohen's d analysis was used to identify associations with increased growth of tumor in the venous sinuses. Logistic regression was used to compare extent of resection with recurrence.
Of the 68 patients included in the study, 34 patients had postoperative residual tumors in the venous sinuses that were measured over time. The growth model that best fit the growth of intrasinus meningiomas was the Gompertzian growth model (r = 0.93). The annual growth rate of meningiomas inside the sinuses was 7.3%, compared to extrasinus tumors with 13.6% growth per year. The only factor significantly associated with increased tumor growth in sinuses was preoperative embolization (effect sizes (ES) [95% CI], 1.874 [7.633-46.735], p = 0.008).
This study shows that meningiomas involving the venous sinuses have a Gompertzian-type growth with early exponential growth followed by a slower growth rate that plateaus when they reach a certain size. Overall, the growth rate of the intrasinus portion is low (7.3%), which is half of the reported growth rates for other studies involving primarily extrasinus tumors.
目前对于位于静脉窦内的脑膜瘤,是采取积极治疗还是保守治疗,尚无共识。本研究的目的是确定窦内脑膜瘤的生长方式,报告并比较不同静脉窦内、外肿瘤成分的生长速度,确定与肿瘤生长增加相关的危险因素,并确定切除肿瘤的范围对侵犯硬脑膜静脉窦的脑膜瘤复发的影响。
回顾性分析 2007 年至 2015 年在一家三级医疗机构接受初次非活检性切除、WHO 分级 1 级脑膜瘤侵犯硬脑膜静脉窦的成年患者。采用几种生长模型拟合肿瘤生长率,以评估最准确的模型。采用 Cohen's d 分析识别与静脉窦内肿瘤生长增加相关的因素。采用 logistic 回归比较切除范围与复发的关系。
在纳入研究的 68 例患者中,有 34 例患者术后在静脉窦内有残留肿瘤,并随时间进行了测量。最适合窦内脑膜瘤生长的生长模型是 Gompertz 生长模型(r=0.93)。窦内脑膜瘤的年生长率为 7.3%,而窦外肿瘤的年生长率为 13.6%。唯一与窦内肿瘤生长增加显著相关的因素是术前栓塞(效应量(ES)[95%置信区间],1.874 [7.633-46.735],p=0.008)。
本研究表明,累及静脉窦的脑膜瘤呈 Gompertz 型生长,早期呈指数增长,随后生长速度较慢,当达到一定大小时生长速度趋于平稳。总体而言,窦内部分的生长速度较低(7.3%),是其他主要涉及窦外肿瘤的研究报告的生长速度的一半。